Press Releases :: Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN

Oct 29, 2018 9:00am EDT

Alzamend Neuro™ Secures New Licenses from USF to Treat Alzheimer’s Disease

Oct 24, 2017 10:35pm EDT

Alzamend Neuro™ Launches Pursuit to Secure FDA IND and First Stage Clinicals

Jan 30, 2017 6:00am EST

USF Researcher Develops Therapeutic Vaccine to Combat Alzheimer’s Disease and Neurodegenerative Disorders

Jan 09, 2017 6:00am EST

Alzamend Neuro™ Announces TV Icon Willie Aames as International Spokesperson

Jan 03, 2017 2:05pm EST

Alzamend Neuro Launches Regulation A+ Tier II SEC Qualified Offering

rss_feed News RSS